Edell Michael purchased $2K of SNES
Edell Michael (Chief Executive Officer) purchased 2,000 shares of SenesTech, Inc. (SNES) at an average of $0.87 ($0.85–$0.89) across 2 trades on 2026-09-09.
How this was made
The 30-second read
Why it matters
The purchase is a primary disclosure but its materiality is low due to the small amount and lack of a pre‑arranged plan.
Market read
Routine insider purchase with negligible market impact.
What to watch
Potential upcoming clinical data or partnership announcements not yet disclosed.
Background
SEC Form 4 filings disclose insider transactions; they are primary sources for insider activity.
Ticker impact
CEO Edell Michael bought 2,000 shares of SenesTech, Inc. (SNES) for $1,740 in an open‑market purchase on 2026‑09‑09.
Minimal short‑term impact; price may stay flat.
The transaction size ($1.7k) is trivial relative to market cap and typical daily volume, and no 10b5‑1 plan was used.
Market effects
None; the purchase does not affect the broader biotech sector.
None; limited to SenesTech shareholders.
None; the filing is a routine insider transaction.
Counterpoint
Even small insider buys can precede larger strategic moves; monitor for subsequent filings.
Key entities
- CompanySenesTech, Inc.
Biotech firm listed on Nasdaq under ticker SNES.
- PersonEdell Michael
Chief Executive Officer of SenesTech.